Prof. Dr. İLHAN ÖZTOP

Yayın Ağı

Makaleler 189

1. Impact of Tumor Localization on Early Recurrence After Curative Resection in Pancreatic Ductal Adenocarcinoma

ÇALIŞKAN YILDIRIM E., ÜNEK İ. T., ÖZTOP İ., UZUN M., ÜNEK T., SAĞOL Ö.

Medicina (Lithuania) , cilt.61, sa.10, 2025 (SCI-Expanded)

2. Risk Factors for Lateral Pelvic Lymph Node Metastasis in Rectal Cancer

AYDIN B., Can O. D., ÖNDER S., Duymaz C., BİŞGİN T., BARLIK F., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.123, sa.1, 2025 (SCI-Expanded)

3. Level of Knowledge and Awareness of Newly Diagnosed Cancer Patients About Cancer Diagnosis

Ön S., Güç Z. G., Ellidokuz H., Öztop İ.

İzmir Tepecik Eğitim Hastanesi Dergisi , cilt.1, sa.1, ss.1-2, 2025 (Hakemli Dergi)

4. Inflammation-Associated Long Non-Coding RNAs (lncRNAs) in Chronic Viral Hepatitis-Associated Hepatocellular Carcinoma

Pehlivanoglu B., Aysal A., Agalar C., Egeli T., Ozbilgin M., Unek T., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.41, sa.1, ss.1-8, 2025 (ESCI) Sürdürülebilir Kalkınma

5. The efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in the adjuvant treatment of patients with high-risk invasive HR+/HER2-early breast cancer: A comprehensive updated meta-analysis of randomized clinical trials

KESKİNKILIÇ M., ARAYICI M. E., BAŞBINAR Y., ELLİDOKUZ H., YAVUZŞEN T., ÖZTOP İ.

Breast , cilt.78, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Relationship between clinicopathological parameters and EGFR mutation status in non-small cell lung carcinomas and correlation of PD-L1 expression

Cagaptay S., Gurel D., AYSAL AĞALAR A., Ulukus C., CANASLAN K., KARAÇAM V., et al.

VIRCHOWS ARCHIV , cilt.485, 2024 (SCI-Expanded)

7. Is the percentage of hormone receptor positivity in HR+HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?

Keskinkilic M., Semiz H. S., Yavuzsen T., Öztop İ.

FRONTIERS IN ONCOLOGY , cilt.14, 2024 (SCI-Expanded, Scopus)

8. lncRNA XIST Interacts with Regulatory T Cells within the Tumor Microenvironment in Chronic Hepatitis B-Associated Hepatocellular Carcinoma

Pehlivanoglu B., Aysal A., Agalar C., Egeli T., Ozbilgin M., Unek T., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.40, sa.2, ss.101-108, 2024 (ESCI)

9. The prognostic significance of PD-1 and its ligands in non-small cell lung cancer.

Usluer O., Gökbayrak Ö. E., Erol A., Aktaş T. Ç., Batıhan G., Kaya Ş. Ö., et al.

Turk gogus kalp damar cerrahisi dergisi , cilt.32, sa.1, ss.84-92, 2024 (SCI-Expanded)

10. The Use of Patient-Reported Outcome Measures in Oncology: Perspectives of Oncologists

ÇALIŞKAN YILDIRIM E., UZUN M., ÖZTOP İ., YAVUZŞEN T.

Journal of Oncological Science , cilt.10, sa.3, ss.125-131, 2024 (Scopus) Sürdürülebilir Kalkınma

11. The Relationship between Exercise Capacity and Muscle Strength, Physical Activity, Fatigue and Quality of Life in Patients with Cancer Cachexia

Polat K., KARADİBAK D., Güç Z. G. S., YAVUZŞEN T., ÖZTOP İ.

Nutrition and Cancer , cilt.76, sa.1, ss.55-62, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma

Ellez H. I., Keskinkilic M., SEMİZ H. S., ARAYICI M. E., Kisa E., ÖZTOP İ.

JOURNAL OF CLINICAL MEDICINE , cilt.12, sa.17, 2023 (SCI-Expanded, Scopus)

13. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

Hizal M., Bilgin B., Paksoy N., Atci M. M., Kahraman S., Kilickap S., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.149, 2023 (SCI-Expanded)

14. The effect of inflammatory-nutri̇tional prognosti̇c scori̇ng (INPS) system on treatment response and prognosi̇s i̇n pati̇ents wi̇th locally advanced gastroesophageal juncti̇on and gastri̇c cancer wi̇th neoadjuvant systemi̇c treatment.

Keskinkilic M., Yalcin F., Gozmen T., Ellidokuz H., Yavuzsen T., Oztop I.

JOURNAL OF CLINICAL ONCOLOGY , cilt.41, sa.16, ss.16092, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Association of Serum Hepatocyte Growth Factor Level with Systemic Inflammatory Biomarkers in Patients with Pancreatobiliary Cancer

Ünek İ. T., Öztop İ., Başbınar Y., Ünek T., Leblebici A., Çakıroğlu E., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.34, sa.5, ss.568-575, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

16. The Evaluation of the Effect of Inflammatory-Nutritional Prognostic Scoring (INPS) System on Treatment Response and Prognosis in Patients with Locally Advanced Breast Cancer Treated with Neoadjuvant Systemic Treatment

Keskinkiliç M., Yalçin F., Okumuş A., Polat G., Ateş Ü., Ellidokuz H., et al.

ANNALS OF ONCOLOGY , cilt.8, ss.101220, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

17. The Effect of Hormone Receptor Positive Percentage On Treatment Response And Prognosis In HR+ HER2- Metastatic Breast Cancer Receiving CDK 4/6 Inhibitor + Endocrine Treatment

Keskinkiliç M., Semiz H. S., Yavuzşen T., Öztop I.

ANNALS OF ONCOLOGY , cilt.8, ss.101223, 2023 (Düzenli olarak gerçekleştirilen hakemli kongrenin bildiri kitabı) Sürdürülebilir Kalkınma

18. Predictors of the 6-min walk test in patients with ovarian cancer

Kizilirmak A. S., KARADİBAK D., Gultekin S. C., Ozsoy I., Yavuzsen H. T., YAVUZŞEN T., et al.

SUPPORTIVE CARE IN CANCER , cilt.31, sa.4, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. The Prognostic Significance of Circulating Tumor Cells in Patients with Pancreatobiliary Cancer

Ünek İ. T., Öztop İ., Başbınar Y., Ünek T., Leblebici A., Karaca C., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.34, sa.3, ss.278-286, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

20. The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index

KESKİNKILIÇ M., SEMİZ H. S., POLAT G., Arayici M. E., YAVUZŞEN T., ÖZTOP İ.

FUTURE ONCOLOGY , cilt.19, ss.517-529, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy

Çelik H., Barlık F., Sökmen S., Terzi C., Canda A. E., Sağol Ö., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.29, sa.2, ss.219-227, 2023 (SCI-Expanded)

22. Tumoral and Parenchymal Morphological Assessment in Liver Metastases of Colorectal Carcinoma: Micrometastasis, Peritumoral Lymphocytes, Tumor Budding and Differentiation are Potential Prognostic Factors

Aysal Ağalar A., Ağalar C., Egeli T., Özbilgin M., Ünek T., Somalı I., et al.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY , cilt.30, sa.8, ss.861-871, 2022 (SCI-Expanded, Scopus)

23. Lung Cancer in Turkey

KAYI CANGIR A., Yumuk P. F., SAK S., AKYÜREK S., ERALP Y., Yilmaz U., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.17, sa.10, ss.1158-1170, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Do different ALK positivity rates affect treatment response and prognosis in non small cell carcinoma of the lung?

Yumuk E., Agalar A. A., Gurel D., Arslan M., Keser M., Ulukus C., et al.

VIRCHOWS ARCHIV , cilt.481, sa.SUPPL 1, 2022 (SCI-Expanded)

25. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Hizal M., Bilgin B., Paksoy N., Kılıçkap S., Atcı M. M., Kahraman S., et al.

FUTURE ONCOLOGY , cilt.18, sa.23, ss.2573-2582, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Peritumoral histopathologic findings in patients with chronic viral hepatitis-associated hepatocellular carcinoma

PEHLİVANOĞLU B., AYSAL AĞALAR A., AĞALAR C., EGELİ T., Ozbilgin M., ÜNEK T., et al.

APMIS , cilt.130, sa.6, ss.346-356, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Symptom clusters in patients with lung cancer patients receiving chemotherapy Kemoterapi alan akciğer kanserli hastalarda semptom kümelerinin belirlenmesi

Uğur Ö., Mert H., Karadağ E., Soydaner Karakuş H., Yavuzşen T., Öztop İ., et al.

Adıyaman Üniversitesi Sağlık Bilimleri Dergisi , cilt.8, sa.1, ss.17-26, 2022 (Hakemli Dergi)

28. Symptom clusters in patients with lung cancer patients receiving chemotherapy

Uğur Ö., Mert H., Karadağ E., Karakuş H. S., Yavuzşen T., Öztop İ., et al.

Adıyaman Üniversitesi Sağlık Bilimleri Dergisi , cilt.8, sa.2, ss.17-26, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

29. TISSUE PROCESSING AND ISOLATION OF TUMOR CELLS FROM HUMAN COLORECTAL CANCER TISSUE

Ellidokuz E. B., Sever T., Çalıbaşı Koçal G., Canda A. E., Sarıoğlu S., Kurter H., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.6, sa.3, ss.872-876, 2022 (ESCI)

30. The Lived Experiences of the Partners of Breast Cancer Survivors: Psychosocial Difficulties and Changes

ŞENGÜN İNAN F., GÜNÜŞEN N., KESER M., ÖZTOP İ.

Acibadem Universitesi Saglik Bilimleri Dergisi , cilt.13, sa.1, ss.189-196, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

31. Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis

AYSAL AĞALAR A., AĞALAR C., EGELİ T., ÜNEK T., ÖZTOP İ., BARLIK OBUZ F., et al.

ENDOCRINE PATHOLOGY , cilt.32, sa.4, ss.461-472, 2021 (SCI-Expanded, Scopus)

32. PROGNOSTIC FACTORS AND PROGNOSTIC INDEX FOR PATIENTS WITH ADVANCED PANCREATIC CANCER Single Center Experience and Review of the Literature

ÜNEK İ. T., ÜNEK T., KOCA D., AKMAN T., SALMAN T., ELLİDOKUZ H., et al.

JOURNAL OF B.U.ON. , cilt.26, sa.6, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Combination of gemcitabine, infusional 5-fluorouracil and high-dose folinic acid (GEMFUFOL) as adjuvant chemotherapy in resected pancreatic cancer

ÜNEK İ. T., ÖZTOP İ., Koca D., ÜNEK T., AYSAL AĞALAR A., GÜÇ Z. G., et al.

Journal of B.U.ON. , cilt.26, sa.6, ss.2496-2504, 2021 (SCI-Expanded)

34. **GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients**

Peled N., Gillis R., Kilickap S., Froesch P., Orlov S., Filippova E., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.16, sa.3, 2021 (SCI-Expanded)

35. THE RELATIONSHIP BETWEEN FRAILTY AND SARCOPENIA IN OLDER ADULTS WITH CANCER

ÖZKAYA SAĞLAM B., KÜÇÜKGÜÇLÜ Ö., ÖZCAN M. A., ÖZTOP İ.

Turk Geriatri Dergisi , cilt.24, sa.4, ss.478-489, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

36. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Peled N., Gillis R., KILIÇKAP S., Froesch P., Orlov S., Filippova E., et al.

LUNG CANCER , cilt.148, ss.48-54, 2020 (SCI-Expanded)

37. EGFR mutation status in a series of Turkish non-small cell lung cancer patients

Çalıbaşı Koçal G., Amirfallah A., Sever T., Unal O. U., Gürel D., Öztop İ., et al.

BIOMEDICAL REPORTS , cilt.13, sa.2, 2020 (ESCI, Scopus)

38. A cross-sectional optical coherence tomography study in patients on taxane-based therapy and a case report with the literature review

KAYA M., ATAŞ F., Gulsum Guc Z., ÖZTOP İ., DURAK İ., SAATCİ A. O.

CUTANEOUS AND OCULAR TOXICOLOGY , cilt.39, sa.3, ss.287-293, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

39. Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer

Terzi C., Bingul M., Arslan N. C., Ozturk E., Canda A. E., IŞIK Ö., et al.

COLORECTAL DISEASE , cilt.22, sa.3, ss.279-288, 2020 (SCI-Expanded)

40. Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma

Ömeroğlu Şimşek G., Agababaoglu I., Dursun D., Ozekinci S., Ercetin P., Ellidokuz H., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY , cilt.28, sa.1, ss.188-196, 2020 (SCI-Expanded, Scopus, TRDizin)

41. Prognostic Significance of Hematological Parameters in Patients with Early-Stage Malignant Melanoma

Semiz H. S., KAZAZ S. N., Demir N., Guc Z. G., YAVUZŞEN T., ELLİDOKUZ H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.2, ss.103-109, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

42. Approach to the Geriatric Patient with Lung Cancer

Unal S., ÖZTOP İ.

TIBBI ONKOLOJI - GERIATRIK ONKOLOJI , ss.62-69, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

43. An Evaluation of the Information Sources of Cancer Patients' Relatives. A Prospective Survey

Yildirim S., KAZAZ S. N., Semiz H. S., YAVUZŞEN T., Somali I., ELLİDOKUZ H., et al.

JOURNAL OF CANCER EDUCATION , cilt.34, sa.5, ss.913-919, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Kilickap S., Demirci U., Bugdayci F., Tural D., Korkmaz T., Paydas S., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.14, sa.10, 2019 (SCI-Expanded)

45. Over Kanserli Kadınlarda Kas Kuvveti, Egzersiz Kapasitesi, Fonksiyonel Mobilite ve Performans Arasındaki İlişki: Pilot Çalışma

KARADİBAK D., Kızılırmak A. S., ÖZSOY İ., Sevgen Güç Z., YAVUZŞEN T., ÖZTOP İ.

Turkish Journal of Physiotherapyand Rehabilitation , cilt.30, sa.2, ss.74, 2019 (Scopus) Sürdürülebilir Kalkınma

46. Kanser kaşeksi tanısı alan hastalarda fonksiyonel kapasite, kavramakuvveti ve periferik kas kuvveti arasındaki ilişkinin incelenmesi

polat k., KARADİBAK D., YAVUZŞEN T., ÖZTOP İ., Sevgen Güç Z.

Turkish Journal of Physiotherapy and Rehabilitation , cilt.30, sa.2, ss.74, 2019 (Scopus) Sürdürülebilir Kalkınma

47. Can Inflammatory and Nutritional Serum Markers Predict Chemotherapy Outcomes and Survival in Advanced Stage Nonsmall Cell Lung Cancer Patients?

Cehreli R., Yavuzşen T., Ateş H., Akman T., Ellidokuz H., Öztop İ.

BIOMED RESEARCH INTERNATIONAL , cilt.2019, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Long-Term Survival With Salvage Surgery in Persistent Lung Cancer

Er I., Kirli M., Cetinayak O., AYDIN B., Akturk N., KARAÇAM V., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.3, sa.3, ss.199-200, 2019 (ESCI) Sürdürülebilir Kalkınma

49. DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients

Amirfallah A., Çalıbaşı Koçal G., Unal O. U., Ellidokuz H., Öztop İ., Başbınar Y.

JOURNAL OF PERSONALIZED MEDICINE , cilt.8, sa.4, 2018 (SCI-Expanded, Scopus)

50. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma

Oktay E., Oflazoglu U., Varol Y., TANRIVERDİ Ö., Mermur N., Arda H. U., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, 2018 (SCI-Expanded)

51. Is It Useful To Determine ERCC1 Expression In Early Stage Non-Small Cell Lung Carcinomas?

ERSÖZ H., AĞABABAOĞLU İ., ÇAKMAKOĞLU Ş., GÜREL D., ATABEY S. N., ÖZTOP İ., et al.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , cilt.32, sa.3, ss.173-182, 2018 (Hakemli Dergi)

52. Tumor deposits in salivary gland tumors

SARIOĞLU S., Kilicarslan E., AYDIN B., Kozen M. A., AKMAN F., ÖZTOP İ., et al.

PATHOLOGY INTERNATIONAL , cilt.68, sa.3, ss.183-189, 2018 (SCI-Expanded, Scopus)

53. Retesting the psychometric characteristics of the European cancer research and treatment organization’s quality of life questionnaire palliative care 15 Turkish version (EQRTC QLQ C15-PAL) and evaluating the influencing factors

YAVUZŞEN T., Sevgen Güç Z., UĞUR Ö., BEKTAŞ M., ÖZTOP İ.

Joutnal of Oncological Sciences , cilt.4, sa.-, ss.35-39, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

54. The Importance of Investigating Tumor Biology and Biomarkers in Pleural Effusions

Görgülü B., Akkoçlu A., AKTAŞ S., ALTUN Z. S., DEMİR A. B., Pamukoğlu A., et al.

Journal of Molecular Biomarkers Diagnosis , cilt.9, sa.05, 2018 (Hakemli Dergi)

55. Immune Checkpoint Inhibitors in Advanced-Stage Non-small Cell Lung Cancer

KAZAZ S. N., ÖZTOP İ.

TURKISH THORACIC JOURNAL , cilt.18, sa.4, ss.101-107, 2017 (ESCI) Sürdürülebilir Kalkınma

56. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., Tastekin D., Akyol M., et al.

CLINICAL COLORECTAL CANCER , cilt.16, sa.3, ss.220-227, 2017 (SCI-Expanded)

57. Treatment After First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small- Cell Lung Cancer

KAZAZ S. N., ÖZTOP İ.

TURKISH THORACIC JOURNAL , cilt.18, sa.3, ss.66-71, 2017 (ESCI)

58. The Use of Neutrophil/Lymphocyte Ratio (Nlr), Platelet/Lymphocyte Ratio (Plr), and Mean Platelet Volume (Mpv) As Inflammatory Biomarkers in the Prognosis of Patients with Early-Stage Colorectal Adenocarcinoma

Buyruk A. M., KAZAZ S. N., ÖZTOP İ., Semiz H. S., Oflazoglu U., Somali I.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.27, sa.4, ss.220-228, 2017 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

59. Prognostic Value of Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR) and Mean Platelet Volume (MPV) In Patients with Colorectal Carcinoma [Izmir Oncology Group(IZOG) Study]

OFLAZOĞLU U., ALACACIOĞLU A., SOMALI I., YÜCE M., BUYRUK A. M., VAROL U., et al.

ACTA ONCOLOGICA TURCICA , cilt.50, sa.1, ss.1-6, 2017 (Hakemli Dergi)

60. Treatment After Crizotinib Resistance in ALK plus Non-Small-Cell Lung Cancer

Kazaz S. N., ÖZTOP İ.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.27, sa.1, ss.60-68, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

61. Kolorektal Kanser ve İmmunoterapi

Çokmert S., ALTUN Z. S., ÖZTOP İ., AKTAŞ S., OLGUN H. N.

DEÜ Tıp Fakültesi dergisi , cilt.30, sa.3, ss.131-137, 2016 (Hakemli Dergi) Sürdürülebilir Kalkınma

62. Case Report of a Renal Cell Carcinoma Patient with Acute Pancreatitis Under Both Sunitinib and Axitinib Treatment

OFLAZOĞLU U., VAROL U., ALACACIOĞLU A., SALMAN T., DEMİR N., SEMİZ H. S., et al.

Journal of oncological sciences , cilt.2, sa.2, ss.63-65, 2016 (Hakemli Dergi)

63. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1

BAŞBINAR Y., ÇALIBAŞI KOÇAL G., Kucukzeybek B. B., Akbarpour M., Kayacik N., SAĞOL Ö., et al.

ONCOLOGY RESEARCH , cilt.24, sa.1, ss.41-53, 2016 (SCI-Expanded, Scopus)

64. The association of clinicopathological features and survival in colorectal cancer patients with kras mutation status

Akman T., ÖZTOP İ., BAŞBINAR Y., ÜNEK İ. T., DEMİR N., ELLİDOKUZ H., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.12, sa.1, ss.96-102, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. The prognostic value of morphologic findings for lung squamous cell carcinoma patients.

GÜREL D., Ulukus C., KARAÇAM V., ELLİDOKUZ H., UMAY C., ÖZTOP İ., et al.

Pathology, research and practice , cilt.212, sa.1, ss.1-9, 2016 (SCI-Expanded, Scopus)

66. The value of liver-based standardized uptake value and other quantitative F-18-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology

Koc M., ÇAPA KAYA G., Demir Y., Sürücü E., SARIOĞLU S., BARLIK OBUZ F., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.36, sa.9, ss.898-907, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

67. Entropy in colon adenocarcinoma

Cakir Y., Sarioglu S., Unlu M., Sagol Ö., SÖKMEN S., Canda A. E., et al.

VIRCHOWS ARCHIV , cilt.467, 2015 (SCI-Expanded)

68. he value of liver based standardized uptake value and other quantitative 18F FDG PET CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer correlation with histopathology

KOÇ M., KAYA G. Ç., DEMİR Y., SÜRÜCÜ E., SARIOĞLU S., OBUZ F., et al.

Nuclear Medicine Community , 2015 (Hakemli Dergi) Sürdürülebilir Kalkınma

69. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

TURAN N., BENEKLİ M., Unal O. U., ÜNEK İ. T., Tastekin D., DANE F., et al.

CHINESE JOURNAL OF CANCER RESEARCH , cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded)

70. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study

Abali H., ÇELİK İ., Karaca B., TURNA Z. H., KAYTAN SAĞLAM E., Akman T., et al.

JOURNAL OF BUON , cilt.20, sa.4, ss.1137-1141, 2015 (SCI-Expanded)

71. Dihydropyrimidine dehydrogenase 85T>C mutation is associated with ocular toxicity of 5-fluorouracil: a case report.

Başbınar Y., Amirfallah A., Unal O. U., Calibasi G., Öztop İ.

American journal of therapeutics , cilt.22, sa.2, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

72. Diffusion-weighted MRI and MR- volumetry - in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer

Birlik B., BARLIK OBUZ F., Elibol F. D., Celik A. O., SÖKMEN S., Terzi C., et al.

MAGNETIC RESONANCE IMAGING , cilt.33, sa.2, ss.201-212, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

73. Adulthood hepatoblastoma

Akman T., Oktan M. A., ÜNEK İ. T., ÜNEK T., ÖZTOP İ., YAVUZŞEN T., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.26, sa.1, ss.73-74, 2015 (SCI-Expanded, Scopus, TRDizin)

74. The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy

Akman T., ÖZTOP İ., BAŞBINAR Y., Akbarpour M., Unal O. U., Oflazoglu U., et al.

MEDICAL ONCOLOGY , cilt.32, sa.1, 2015 (SCI-Expanded, Scopus)

75. Adult urological soft tissue sarcomas: A multicenter study of the anatolian society of medical oncology (ASMO)

Unal O. U., ÖZTOP İ., Menekse S., Urakci Z., BOZKURT O., Ozcelik M., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.11, ss.4777-4780, 2015 (SCI-Expanded)

76. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study

Salman T., KAZAZ S. N., Varol U., Oflazoglu U., ÜNEK İ. T., KÜÇÜKZEYBEK Y., et al.

CHEMOTHERAPY , cilt.61, sa.6, ss.281-286, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Unal O. U., ÖZTOP İ., Yasar N., Urakci Z., Ozatli T., BOZKURT O., et al.

THORACIC CANCER , cilt.6, sa.1, ss.85-90, 2015 (SCI-Expanded)

78. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

Turan N., BENEKLİ M., DANE F., Unal O. U., KARA H. V., Koca D., et al.

THORACIC CANCER , cilt.5, sa.5, ss.398-404, 2014 (SCI-Expanded)

79. Neutrophil-to-Lymphocyte Ratio: Could it be used in the clinic as Prognostic Marker for Gastrointestinal Stromal Tumor?

ATİLA K., Arslan N. C., Derici S., Canda A. E., SAĞOL Ö., ÖZTOP İ., et al.

HEPATO-GASTROENTEROLOGY , cilt.61, sa.134, ss.1649-1653, 2014 (SCI-Expanded)

80. KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomas.

BAŞBINAR Y., Dagdeviren Y. K., Calibasi G., Canda A. E., SARIOĞLU S., ELLİDOKUZ H., et al.

Journal of gastrointestinal oncology , cilt.5, sa.4, ss.265-9, 2014 (ESCI, Scopus) Sürdürülebilir Kalkınma

81. IS MORE PATHOLOGICAL COMPLETE RESPONSE RATE OBSERVED WHEN SURGERY IS DELAYED 12 WEEKS AFTER COMPLETION OF CHEMORADIOTHERAPY COMPARED TO 8 WEEKS? PRELIMINARY REPORT

Terzi C., Canda A., Bingul M., Arslan N., Unlu M., Gorken İ., et al.

DISEASES OF THE COLON & RECTUM , cilt.57, sa.5, 2014 (SCI-Expanded)

82. FOLFOX7 regimen in the first-line treatment of metastatic colorectal cancer

Koca D., Unal O. U., ÖZTOP İ., Yilmaz U.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.2, ss.198-204, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

83. KRAS and BRAF mutation frequencies in a series of Turkish colorectal cancer patients

BAŞBINAR Y., ÇALIBAŞI KOÇAL G., Amirfallah A., Dagdeviren Y. K., Canda A. E., SARIOĞLU S., et al.

TRANSLATIONAL CANCER RESEARCH , cilt.3, sa.2, ss.160-166, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. **Molecular Analysis of the KIT Gene in Gastrointestinal Stromal Tumors With Novel Mutations**

ÇALIBAŞI KOÇAL G., BAŞBINAR Y., ALYÜRÜK H., ÇAVAŞ L., Oztop İ., Sagol Ö., et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , cilt.22, sa.1, ss.37-45, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

85. Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)

Unal O. U., ÖZTOP İ., Kos T., Turan N., KÜÇÜKÖNER M., Helvaci K., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.22, ss.9687-9692, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

86. Tumor deposits in gastric carcinomas

Ersen A., Unlu M. S., Akman T., SAĞOL Ö., ÖZTOP İ., ATİLA K., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.210, sa.9, ss.565-570, 2014 (SCI-Expanded, Scopus)

87. Impact of Accompanying Comorbidities on Survival in Patients with Stage IIIB- IV Non-Small-Cell Lung Cancer

Demirpence M., Akman T., ÖZTOP İ., ÜNEK İ. T., YAVUZŞEN T., Yilmaz A. U.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.223-232, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

88. Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience

Akman T., ÖZTOP İ., ÜNEK İ. T., Koca D., Unal O. U., Salman T., et al.

CHEMOTHERAPY , cilt.60, sa.4, ss.228-238, 2014 (SCI-Expanded, Scopus)

89. Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Gumusay O., Coskun U., Akman T., Ekinci A. S., Kocar M., Erceleb O. B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.140, sa.1, ss.151-157, 2014 (SCI-Expanded)

90. Survival Outcomes of Liver Metastasectomy in Colorectal Cancer Cases: A Single-Center Analysis in Turkey

Cokmert S., ELLİDOKUZ H., Demir L., Fuzun M., Astarcioglu I., Aslan D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.13, ss.5195-5200, 2014 (SCI-Expanded, Scopus)

91. Treatment and prognostic factors in primary peritoneal carcinoma: A multicenter study of the anatolian society of medical oncology (ASMO)

ÜNAL O., ÖZTOP İ., Yazici O., Ozatli T., Inal A., Günaydin Y., et al.

Oncology Research and Treatment , cilt.37, sa.6, ss.332-338, 2014 (SCI-Expanded)

92. CD40 Expression In Pancreatic Cancer

ÜNEK T., ÜNEK İ. T., AYSAL AĞALAR A., SAĞOL Ö., ELLİDOKUZ H., Ertener O., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.128, ss.2085-2093, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

93. EVALUATION OF GENE EXPRESSION PROFILES FOR THE DIFFERENTIAL DIAGNOSIS OF LUNG ADENOCARCINOMA AND MALIGNANT PLEURAL MESOTHELIOMA

ÖMEROĞLU ŞİMŞEK G., Agababaoglu I., Dursun D., Ozekinci S., Ercetin P., AKTAŞ S., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.8, 2013 (SCI-Expanded)

94. THE IMAGING CHARACTERISTICS OF F-18 FDG PET-CT ON EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS IN NON-SMALL CELL LUNG CANCER

Polack B. D., BAŞBINAR Y., KARAHAN N., ÇALIBAŞI KOÇAL G., BEKİŞ R., Onal O. U., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.8, 2013 (SCI-Expanded)

95. the imaging characteristics of F18 FDG PETCT on epidermal growth factor receptor mutation in non small cell lung cancer

Değirmenci Polack B., Başbınar Y., Karahan N., Çalıbaşı Koçal G., Ünal O., Öztop İ., et al.

European Journal Of Nuclear Medicine And Molecular Imaging , cilt.40, sa.s2, ss.185-186, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

96. Gastrointestinal stromal tümörlerde c-kit proto-onkogeni (KIT) mutasyon sıklıkları: Türkiye’nin Ege Bölgesi kaynaklı populasyon çalışması

Çalıbaşı Koçal G., Baskın Y., Öztop İ., Sağol Ö., Atila K., Ellidokuz H., et al.

TURKISH JOURNAL OF BIOCHEMISTRY , cilt.38, sa.1, ss.5-12, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

97. Evaluation of changes in the attitudes and behaviors of relatives of lung cancer patients toward cancer prevention and screening

Koca D., Oztop İ., Yilmaz U.

INDIAN JOURNAL OF CANCER , cilt.50, sa.3, ss.233-238, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

98. Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma

ÜNEK İ. T., Akman T., ÖZTOP İ., Unal O. U., Salman T., Yilmaz U.

GASTRIC CANCER , cilt.16, sa.3, ss.428-434, 2013 (SCI-Expanded)

99. Protein modelling of a novel KIT mutation (N567Y) in the gastrointestinal stromal tumour

Alyürük H., Çalıbaşı Koçal G., Çavaş L., Başbınar Y., Öztop İ., Ellidokuz H., et al.

EUROPEAN JOURNAL OF CANCER , cilt.49, sa.10, ss.2449-2452, 2013 (SCI-Expanded)

100. Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Canda A. E., SÖKMEN S., Terzi C., Arslan C., ÖZTOP İ., KARABULUT B., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.20, sa.4, ss.1082-1087, 2013 (SCI-Expanded)

101. Clinical Importance of Diastolic Sonoelastographic Scoring in the Management of Thyroid Nodules

Yerli H., Yilmaz T., ÖZTOP İ.

AMERICAN JOURNAL OF NEURORADIOLOGY , cilt.34, sa.3, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

102. Two-Week Combination Chemotherapy with Gemcitabine, High-Dose Folinic Acid and 5 Fluorouracil (GEMFUFOL) as First-Line Treatment of Metastatic Biliary Tract Cancers

Unal O. U., ÖZTOP İ., ÜNEK İ. T., Yilmaz A. U.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.9, ss.5263-5267, 2013 (SCI-Expanded)

103. Relationship between Epidermal Growth Factor Receptor Gene Mutations and Clinicopathological Features in Patients with Non-Small Cell Lung Cancer in Western Turkey

Unal O. U., ÖZTOP İ., ÇALIBAŞI KOÇAL G., BAŞBINAR Y., Koca D., DEMİR N., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.6, ss.3705-3709, 2013 (SCI-Expanded, Scopus)

104. Can only chemoradiotherapy and chemotherapy treatment be applied to patients with rectal cancer who could not be operated?

Koca D., ÖZTOP İ., Yilmaz U.

Journal of Gastrointestinal Oncology , cilt.4, sa.2, ss.193-197, 2013 (Scopus) Sürdürülebilir Kalkınma

105. The frequencies of c-kit proto-oncogene (KIT) mutations in gastrointestinal stromal tumours: a population based study from Aegean Region of Turkey

ÇALIBAŞI KOÇAL G., BAŞBINAR Y., ÖZTOP İ., SAĞOL Ö., ATİLA K., ELLİDOKUZ H., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.38, sa.1, ss.5-12, 2013 (SCI-Expanded, Scopus, TRDizin)

106. Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

Turan N., BENEKLİ M., Koca D., Ustaalioglu B. O., DANE F., Ozdemir N., et al.

ONCOLOGY , cilt.84, sa.1, ss.14-21, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

107. The factors that have an impact on the development of brain metastasis in the patients with breast cancer

Dayan A., Koca D., Akman T., ÖZTOP İ., ELLİDOKUZ H., Yilmaz U.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.8, sa.4, ss.542-548, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Neoadjuvant Chemotherapy Rather than Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer with High Tumor Burden

Koca D., ÖZTOP İ., Yilmaz U.

HEPATO-GASTROENTEROLOGY , cilt.59, sa.119, ss.2151-2154, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

109. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer

Koca D., Binicier C., Oztop İ., YAVUZŞEN T., ELLİDOKUZ H., Yilmaz U.

JOURNAL OF BUON , cilt.17, sa.2, ss.291-298, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.

GÜMÜŞTEKİN M., Kargi A., Bulut G., Gozukizil A., Ulukus C., ÖZTOP İ., et al.

Pathology oncology research : POR , cilt.18, sa.2, ss.209-18, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Bimonthly Regimen of High-Dose Leucovorin, Infusional 5-Fluorouracil, Epirubicin and Cisplatin (Modified ECF) as Adjuvant Chemotherapy in Resected Gastric Adenocarcinoma

ÜNEK İ. T., ÜNEK T., ÖZTOP İ., Akman T., Atilla K., ELLİDOKUZ H., et al.

CHEMOTHERAPY , cilt.58, sa.3, ss.233-240, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. The effect of anxiety and depression on quality of life in turkish non small lung cancer patients Türk küçük hücre dışı akciǧer kanser hastalarında anksiyete ve depresyonun yaşam kalitesine etkisi

Alacacioǧlu A., ÖZTOP İ., Yilmaz U.

Turk Toraks Dergisi , cilt.13, sa.2, ss.50-55, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

113. THE IMPORTANCE OF KIT MUTATIONS IN PERSONALISED CANCER MANAGEMENT OF GIST

Çalıbaşı Koçal G., Başbınar Y., Öztop İ., Sağol Ö., Atilla K., Ellidokuz H., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.36, sa.S1, ss.2, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

114. Lymph Node Staging in Patients with Locally Advanced Rectal Cancer Using PET/CT and Pelvic High Resolution MR

Koc M., ÇAPA KAYA G., BARLIK OBUZ F., SARIOĞLU S., Oztop İ., Gorken İ., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded)

115. The association of complementary alternative medicine use with anxiety, depression and quality of life in Turkish cancer patients

Tarhan O., Alacacioglu A., Somali I., Sipahi H., ZENCİR M., Erten C., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.15, sa.5, ss.274-278, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

116. gastrointestinal stromal tümörlerde kıt geni mutasyonlarının dağılımı

Başbınar Y., Çalıbaşı Koçal G., Öztop İ., Sağol Ö., Atila K., Ellidokuz H., et al.

Turkiye Klinikleri Tip Bilimleri Dergisi , cilt.31, sa.6, ss.41, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

117. CAN MAXIMUM STANDARDIZED UPTAKE (SUVMAX) OF F-18 FDG BE AN INDICATOR OF PREDICTING THE ADJUVANT CHEMOTHERAPY IN EARLY STAGE NON-SMALL CELL LUNG CANCER?

Surucu E., DEMİR C., Demir Y., ÖZTOP İ., Ozdemit N., Akkoclu A., et al.

JOURNAL OF THORACIC ONCOLOGY , sa.6, 2011 (SCI-Expanded)

118. The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer

Turan N., Koca D., Dane F., Ozdemir N., Ustaalioglu B. B. O., Oztop İ., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

119. Adrenalectomy for Isolated Metastasis in Five Patients with Lung Cancer: Single Centre Experience and Review of the Literature

ÜNEK İ. T., KOÇDOR M. A., SEVİNÇ A. İ., Onen A., ÖZDOĞAN Ö., ÖZTOP İ., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.21, sa.4, ss.230-240, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

120. Evaluation of the Efficacy of Modified De Gramont and Modified FOLFOX4 Regimens for Adjuvant Therapy of Locally Advanced Rectal Cancer

Koca D., ÖZTOP İ., YAVUZŞEN T., ELLİDOKUZ H., Yilmaz U.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.12, sa.12, ss.3181-3186, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

121. Clinical and Electrocardiography Changes in Patients Treated with Capecitabine

Koca D., Salman T., ÜNEK İ. T., ÖZTOP İ., ELLİDOKUZ H., Eren M., et al.

CHEMOTHERAPY , cilt.57, sa.5, ss.381-387, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

122. NEOADJUVANT RADIOTHERAPY TREATMENT OUTCOMES IN PATIENTS WITH RECTAL CANCER - EXPER?ENCE OF DOKUZ EYLUL UNIVERSITY COLORECTAL CANCER GROUP (DEKRKG)

Gorken İ., Alicikus Z. A., Tahberer E., SÖKMEN S., Arslan I., Akin M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.96, 2010 (SCI-Expanded)

123. Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer

Oztop İ., Alacacioglu A., ÜNEK İ. T., Tarhan O., Somali I., Cokmert S., et al.

JOURNAL OF BUON , cilt.15, sa.3, ss.462-469, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

124. Oral Amoxicillin/Clavulanate and Ciprofloxacin Treatment in Low-Risk Febrile Neutropenic Patients with Solid Tumors

KURUÜZÜM Z., Oztop I., Yuce A., Yilmaz U., Cakir N.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.30, sa.3, ss.914-918, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

125. Quality of life, anxiety, and depression in Turkish colorectal cancer patients

Alacacioglu A., Binicier O., Gungor O., ÖZTOP İ., Dirioz M., Yilmaz U.

SUPPORTIVE CARE IN CANCER , cilt.18, sa.4, ss.417-421, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

126. Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients

Canda A. E., Terzi C., GÖRKEN İ., ÖZTOP İ., SÖKMEN S., Fuzun M.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , cilt.25, sa.2, ss.197-204, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

127. Targeted Therapy in non-Small Cell Lung Cancer

Oztop I.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.19, sa.3, ss.184-194, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

128. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients

Somali I., Meydan N., Tarhan M. O., Oztop İ., Alacacioglu A., Yilmaz U.

JOURNAL OF BUON , cilt.14, sa.3, ss.429-433, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

129. Burnout in nurses and physicians working at an oncology department

Alacacioglu A., YAVUZŞEN T., Dirioz M., ÖZTOP İ., Yilmaz U.

PSYCHO-ONCOLOGY , cilt.18, sa.5, ss.543-548, 2009 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

130. Complementary-alternative medicine among cancer patients in the western region of Turkey

Tarhan O., Alacacioglu A., Somali I., Sipahi H., Zencir M., Oztop İ., et al.

JOURNAL OF BUON , cilt.14, sa.2, ss.265-269, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

131. Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor

ÜNEK İ. T., ÇELTİK A., Yener S., YAVUZŞEN T., Alacacioglu A., Cokmert S., et al.

JOURNAL OF BUON , cilt.14, sa.1, ss.135-138, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

132. Diabetes insipidus caused by pituitary gland metastasis accompanied by iris metastasis of small cell lung cancer: case presentation and review of the literature

Alacacioglu A., Oeztop İ., Fidan F., Akkoclu A., Kargi A., Osma E., et al.

TUMORI JOURNAL , cilt.94, sa.5, ss.765-768, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

133. Synchronous appearance of male breast cancer and pancreatic cancer 15 years after the diagnosis of testicular cancer - report of a case

ÜNEK İ. T., Alacacioglu A., Tarhan O., Sevinc A. I., Oztop İ., Sagol Ö., et al.

JOURNAL OF BUON , cilt.13, sa.3, ss.421-424, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

134. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey

Yaren A., Ozkilinc G., Guler A., Oztop İ.

EUROPEAN JOURNAL OF CANCER CARE , cilt.17, sa.3, ss.278-284, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

135. The development of metachronous prostate cancer and chronic myeloid leukemia in a patient with metastatic rectal cancer

Oztop İ., Yaren A., Demirpence M., Alacacioglu İ., Tuna B., Piskin O., et al.

JOURNAL OF BUON , cilt.13, sa.2, ss.267-270, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

136. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy

Terzi C., Canda A. E., Sagol O., ATİLA K., Sonmez D., Fuzun M., et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , cilt.23, sa.1, ss.37-45, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

137. Targeted therapy in head and neck cancer

Oeztop İ.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.18, sa.1, ss.46-56, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

138. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non-small-cell lung cancer

YAREN A., ÖZTOP İ., TURGUT S., TURGUT G., Degirmencioglu S., Demirpence M.

EXPERIMENTAL BIOLOGY AND MEDICINE , cilt.233, sa.1, ss.32-37, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

139. The use of trastuzumab in adjuvant setting for early stage breast cancer Erken evre meme kanserinin adjuvan tedavisinde trastuzumab

ÖZTOP İ.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.17, sa.3, ss.184-192, 2007 (Scopus)

140. Insertion/Deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors

Yaren A., Turgut S., Kursunluoglu R., Oztop I., Turgut G., Degirmencioglu S., et al.

JOURNAL OF INVESTIGATIVE MEDICINE , cilt.55, sa.5, ss.255-261, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

141. The use of taxanes in adjuvant setting for early stage breast cancer Erken evre meme kanserinin adjuvan kemoterapisinde taksanlar

ÖZTOP İ.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.17, sa.1, ss.55-64, 2007 (Scopus)

142. 5-fluorouracil increases the number and complexity of premature complexes in the heart: a prospective study using ambulatory ECG monitoring

Yilmaz U., Oztop İ., Ciloglu A., Okan T., Tekin U., Yaren A., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.61, sa.5, ss.795-801, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

143. Syndrome of inappropriate antidiuretic hormone secretion in a patient with advanced bladder cancer

Alacacioǧlu A., AKINCI B., Tarhan O., Gerçeker E., Başaran K., ÖZTOP İ., et al.

Turkish Journal of Cancer , cilt.37, sa.2, ss.69-71, 2007 (Scopus) Sürdürülebilir Kalkınma

144. Syndrome of inappropriate antidiuretic hormone secretion in a patient with advanced the cancer

ALACACIOĞLU A., AKINCI B., TARHAN M. O., GERÇEKER E., BAŞARAN K., ÖZTOP İ., et al.

TURKISH JOURNAL OF CANCER , cilt.37, sa.2, ss.69-71, 2007 (Scopus)

145. Göğüs duvarı (T3) ve vertebra (T4) tutulumu olan küçük hücreli dışı akciğer kanseri olgularında cerrahi tedavi

ŞANLI A., ÖNEN A., YÜCESOY K., KARAÇAM V., GÖKÇEN B., EYÜBOĞLU G. M., et al.

Tüberküloz ve Toraks , cilt.55, sa.4, ss.383-389, 2007 (Scopus) Sürdürülebilir Kalkınma

146. Gastric carcinoma during pregnancy: Report of a case

ÜNEK İ. T., ÇELTİK A., Alacacioglu A., Cokmert S., YAVUZŞEN T., Dogan N. S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.1, ss.41-43, 2007 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

147. Survivin expression in non-small-cell lung carcinomas: Correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis

Ulukus E. Ç., Kargi H. A., Sis B., Lebe B., Oztop I., Akkoclu A., et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , cilt.15, sa.1, ss.31-37, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

148. Prognoztic factors in non-small cell lung cancer: Review

YAREN A., ÖZTOP İ.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.27, sa.1, ss.72-78, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

149. MDCT findings in neuroendocrine carcinoma of the gallbladder: case report

BARLIK OBUZ F., ALTAY C., Sagol Ö., Astarcioglu H., Oztop İ., Igci E.

ABDOMINAL IMAGING , cilt.32, sa.1, ss.105-107, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

150. Late pulmonary metastasis of renal cell carcinoma after nephrectomy

Alacacioglu A., Solmaz D., Oztop I., Yilmaz U.

SAUDI MEDICAL JOURNAL , cilt.28, sa.2, ss.286-287, 2007 (SCI-Expanded)

151. [Surgical treatment in non-small cell lung cancer invading to the chest wall (T3) and vertebra (T4)].

ŞANLI A., Önen A., Yücesoy K., KARAÇAM V., Karapolat S., Gökçen B., et al.

Tuberkuloz ve toraks , cilt.55, sa.4, ss.383-9, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

152. Surgical treatment in non-small cell lung cancer invading to the chest wall (T3) and vertebra (T4)

ŞANLI A., Önen A., Yücesoy K., KARAÇAM V., Karapolat S., Gökçen B., et al.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , cilt.55, 2007 (Scopus, TRDizin) Sürdürülebilir Kalkınma

153. Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients

Yaren A., Turgut S., Kursunluoglu R., Oztop I., Turgut G., Kelten C., et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.210, sa.2, ss.109-116, 2006 (SCI-Expanded)

154. Metastasis of giant cell tumor to the breast: Case report and review of the literature

Alacacioglu A., BENGİ G., Oztop I., Canda T., Balci P., Osma E., et al.

TUMORI , cilt.92, sa.4, ss.351-353, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

155. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis

Yaren A., Oztop İ., Kargi A., Ulukus C., Onen A., Sanli A., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.60, sa.6, ss.675-682, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

156. Ameliyat sonrası radyoterapi uygulanmış yumuşak doku sarkomlarında tedavi sonuçları ve prognostik faktörler

DEMİRAL A. N., şen m., ÇETİNAYAK H. O., METCALFE E., HAVITÇIOĞLU H., manisalı m., et al.

TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.21, ss.119-124, 2006 (Hakemli Dergi)

157. Adjuvant chemotherapy for early-stage non-small cell lung cancer: Review Erken evre küçük hücreli dişi akciǧer kanserinde adjuvan kemoterapi

Yaren A., ÖZTOP İ.

Turkiye Klinikleri Journal of Medical Sciences , cilt.26, sa.6, ss.649-654, 2006 (Scopus)

158. Postoperative concomitant chemoradiotherapy for gastric cancer at out patient clinic (The preliminary results of protocol)

GÖRKEN İ., Bayman E., Bora S., ÖZTOP İ., Yilmaz U., Alanyali H., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.21, sa.4, ss.178-184, 2006 (ESCI) Sürdürülebilir Kalkınma

159. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.

Çetingöz R., ÇETİNAYAK H. O., Şen R., DEMİRAL A. N., Akkoçlu A., Osma E., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.11, sa.1, ss.31-7, 2006 (Scopus) Sürdürülebilir Kalkınma

160. Prognostic factors in soft tissue sarcoma patients treated with postoperative radiotherapy

DEMİRAL A. N., Şen M., ÇETİNAYAK H. O., Bayman E., Havitçioğlu H., Manisalı M., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.21, sa.3, ss.119-124, 2006 (ESCI, TRDizin) Sürdürülebilir Kalkınma

161. Irinotecan combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced gastric carcinoma as the first-line chemotherapy

Yilmaz U., Oztop İ., Alacacioglu A., Yaren A., Tarhan O., Somali I.

CHEMOTHERAPY , cilt.52, sa.5, ss.264-270, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

162. A patient with rectum cancer, and subcutaneous and pulmonary metastases

TARHAN M. O., Solmaz D., ÖZTOP İ., Tarhan O., Yaren A., Yassin S., et al.

BREATHE , cilt.2, sa.2, ss.179-182, 2005 (ESCI) Sürdürülebilir Kalkınma

163. Ductal carcinoma in situ Duktal karsinoma i̇n situ

ÖZTOP İ.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.15, sa.4, ss.219-228, 2005 (Scopus)

164. Expression of transforming growth factor-beta-1 and p27^Kip1 in pancreatic adenocarcinomas:: relation with cell-cycle-associated proteins and clinicopathologic characteristics -: art. no. 98

Culhaci N., Sagol Ö., Karademir S., Astarcioglu H., Astarcioglu I., Soyturk M., et al.

BMC CANCER , cilt.5, 2005 (SCI-Expanded)

165. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma

Sagol Ö., YAVUZŞEN T., Oztop İ., Ulukus C., Yilmaz U., Alakavuklar M., et al.

PANCREAS , cilt.30, sa.4, ss.343-348, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

166. Cardiotoxicity of de Gramont's regimen: Incidence, clinical characteristics and long-term follow-up

Meydan N., Kundak I., YAVUZŞEN T., Oztop İ., Barutca S., Yilmaz U., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.35, sa.5, ss.265-270, 2005 (SCI-Expanded, Scopus)

167. 5-Fluorouracil-based adjuvant chemotherapy results in the treatment of colorectal cancer patients between 1993 and 2002 1993-2002 Yillari arasinda kolorektal kanserli hastalarda uygulanan 5-fluorourasil temelli adjuvan tedavi sonuçlari

Somali I., ÖZTOP İ., Füzün M., Küpelioǧlu A., BARLIK F., SOYTÜRK M., et al.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.15, sa.1, ss.29-36, 2005 (Scopus)

168. Efficiency and tolerability of 5-fluorouracil-based adjuvant chemotherapy in elderly patients with colorectal carcinoma

ÖZTOP İ., Yaren A., Somali I., Tarhan O., Yilmaz U.

Turkish Journal of Cancer , cilt.34, sa.4, ss.139-145, 2004 (Scopus) Sürdürülebilir Kalkınma

169. Plasma tissue factor levels in patients with colon cancer receiving infusional 5-fluorouracil chemotherapy İnfüzyonel 5-fluorourasil kemoterapisi alan kolon kanserli hastalarda plazma doku faktörü düzeyleri

ÖZTOP İ., ATEŞ H., ALACACIOĞLU A., Yaren A., TARHAN M. O., Alakavuklar M., et al.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.14, sa.3, ss.147-152, 2004 (Scopus)

170. İnfüzyonel 5 Fluorourasil kemoterapisi Alan Kolon Kanserli Hastalarda Plazma Doku Faktörleri Düzeyleri

Öztop İ., Ateş H., Alacacıoğlu A., Yaren A., Tarhan M. O., Alakavuklar M., et al.

TÜRK HEMATOLOJİ-ONKOLOJİ DERGİSİ , cilt.14, sa.3, ss.147-152, 2004 (Hakemli Dergi) Sürdürülebilir Kalkınma

171. Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan

Oztop İ., Demirkan B., Yaren A., Tarhan O., Sengul B., Ulukus C., et al.

TUMORI , cilt.90, sa.5, ss.514-516, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

172. Central venous access system complications in patients with solid tumors Kanserli hastalarda uzun süreli kalici santral venöz kateter komplikasyonlari

ÖZTOP İ., YAVUZŞEN T., Yilmaz U., ÇAVDAR C., Yaren A., Tarhan O., et al.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.14, sa.2, ss.90-95, 2004 (Scopus)

173. Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers

Oztop İ., Gencer M., Okan T., Yaren A., Altekin E., Turker S., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.34, sa.5, ss.262-268, 2004 (SCI-Expanded)

174. Kanserli Hastalarda Uzun Süreli Kalıcı Santral Venöz Kateter Komplikasyonları

ÖZTOP İ., YAVUZŞEN T., YILMAZ A. U., ÇAVDAR C., YAREN A., TARHAN M. O., et al.

TÜRK HEMATOLOJİ-ONKOLOJİ DERGİSİ , cilt.14, sa.2, ss.90-95, 2004 (Scopus)

175. Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas

Oztop İ., Yilmaz U., YAVUZŞEN T., Yaren A., Tarhan O., Sagol Ö., et al.

CHEMOTHERAPY , cilt.50, sa.3, ss.127-132, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

176. The effect of apoptotic activity, survivin, Ki-67 and p-glycoprotein expressions on prognosis in pancreatic carcinoma

Yilmaz U., SAĞOL Ö., YAVUZŞEN T., ÖZTOP İ., Ulukus C., SOYTÜRK M., et al.

ANNALS OF ONCOLOGY , cilt.15, ss.22, 2004 (SCI-Expanded)

177. The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition

Oztop İ., Demirkan B., Tarhan O., Kayahan H., Yilmaz U., Kargi A., et al.

TUMORI JOURNAL , cilt.90, sa.1, ss.132-135, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

178. The use of complementary alternative medicine among cancer patients in the western region of Turkey

Tarhan O., Alacacioglu A., ZENCİR M., ÖZTOP İ.

ANNALS OF ONCOLOGY , cilt.15, ss.214, 2004 (SCI-Expanded)

179. The efficiency and tolerability of 5 Fluorouracil based adjuvant chemotherapy in elderly patients with colorectal cancer A ten years experience of a single institute

ÖZTOP İ., YAREN A., SOMALI I., TARHAN M. O., ALAKAVUKLAR M., YILMAZ A. U.

TURKISH JOURNAL OF CANCER , cilt.34, ss.4139-4145, 2004 (Hakemli Dergi)

180. 5-fluorouracil increases the number and complexity of premaure contractions in the heart: a prospective study using ambulatory ECG monitoring

ÖZTOP İ., Ciloglu A., Okan T., Tekin U., Yaren A., YAVUZŞEN T., et al.

ANNALS OF ONCOLOGY , cilt.15, ss.108-109, 2004 (SCI-Expanded)

181. Gastric cancer diagnosed in a patient with crescentic glomerulonephritis

YAVUZŞEN T., ÖZTOP İ., Yilmaz U., ÇAVDAR C., Sifil A., SARIOĞLU S., et al.

Gastric Cancer , cilt.6, sa.4, ss.267-269, 2003 (SCI-Expanded)

182. OUR EXPERIENCE OF PATIENTS WITH SOFT TISSUE SARCOMAS TREATED BETWEEN 1990 AND 2002

ÖZTOP İ., YILMAZ A. U., HAVITÇIOĞLU H., şen m., DEMİRKAN H. M. B., ÖZKAL S., et al.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.13, sa.2, ss.61-71, 2003 (SCI-Expanded)

183. Refractory thrombocytopenia with multilineage dysplasia: A rare type of myelodysplastic syndrome

DEMİRKAN F., ÖZSAN G. H., ÖZCAN M. A., Vural F., ÖZTOP İ., Yüksel E., et al.

Turkish Journal of Haematology , cilt.20, sa.1, ss.25-30, 2003 (SCI-Expanded)

184. Spontaneous remission in acute leukemia: A report of two cases

ÖZSAN G. H., DEMİRKAN F., ÖZTOP İ., ÖZCAN M., Vural F., ÜNDAR B.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.12, sa.2, ss.99-102, 2002 (Scopus)

185. İleri evre küçük hücreli dışı akciğer kanserinde Sisplatin Gemsitabin kemoterapisinin etkililiği

ÖZTOP İ., YAVUZŞEN T., TEKİŞ D., YILMAZ A. U., DEMİRKAN H. M. B., AKKOÇLU A., et al.

TURKISH THORACIC JOURNAL , cilt.3, sa.3, ss.273-278, 2002 (Hakemli Dergi) Sürdürülebilir Kalkınma

186. Concurrent diagnosis of hairy cell leukemia and renal cell carcinoma

Undar B., DEMİRKAN F., Oztop İ., Ozcan M. A., Ozsan G. H.

LEUKEMIA & LYMPHOMA , cilt.42, sa.3, ss.567-568, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

187. Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia

DEMİRKAN F., Oztop İ., Ozsan H., Undar B.

LEUKEMIA & LYMPHOMA , cilt.42, sa.1-2, ss.251-252, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

188. The use of different prognostic systems applied to myelodysplastic syndromes: A retrospective analysis

DEMİRKAN F., ÇABUK M., ÖZSAN G. H., Pehlivan M., Yuksel E., ÖZTOP İ., et al.

Turkish Journal of Haematology , cilt.17, sa.3, ss.101-109, 2000 (SCI-Expanded)

189. The Role of Interleukin-1 Inhibitors on Acute Myeloblastic Leukemia Blast Proliferation; Future Potential for Biotherapy.

Çehreli C., Özsan G. H., Demirkan F., Ateş H., Ündar B., Akyol F., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.16, sa.4, ss.161-6, 1999 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 132

1. The effect of inflammatory-nutritional prognostic scoring (INPS) system on treatment response and prognosis in patients with locally advanced gastroesophageal junction and gastric cancer with neoadjuvant systemic treatment

Keskinkilic M., Yalcin F., Gozmen T., Ellidokuz H., YAVUZŞEN T., Oztop I.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2023, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Spontaneous mutational frequency of EGFR gene in Turkish non-small cell lung cancer patients and the importance of country-based differences

ÇALIBAŞI KOÇAL G., AMİRFALLAH A., SEVER T., ÜNAL O. Ü., GÜREL D., ÖZTOP İ., et al.

3. International Hippocrates Congress on Medical and Health Sciences, Ankara, Türkiye, 6 - 07 Mart 2020, ss.43-44, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Optimization of Patient-Derived Colorectal Cancer Organoids Protocols for Personalized Drug Screenings.

Sever T., Daşkın E., Mısırlıoğlu K., Çalıbaşı Koçal G., Sarıoğlu S., Canda A. E., et al.

2nd International Cancer and Ion Channel Congress, İzmir, Türkiye, 22 - 24 Eylül 2019, cilt.44, ss.24-69, (Tam Metin Bildiri)

4. YAŞLI MALİGNİTELİ HASTALARDA KIRILGANLIK VE SARKOPENİ İLİŞKİSİ

ÖZKAYA B., KÜÇÜKGÜÇLÜ Ö., ÖZCAN M. A., ÖZTOP İ.

8. Ulusal Geriatrik Hematoloji Kongresi, Türkiye, 27 - 29 Eylül 2019

5. Kanser kaşeksi tanısı alan hastalarda fonksiyonel kapasite, kavrama kuvveti ve periferik kas kuvveti arasındaki ilişkinin incelenmesi

POLAT K., KARADİBAK D., YAVUZŞEN T., ÖZTOP İ., Sevgen Güç Z.

7. Ulusal Fizyoterapi Rehabilitasyon kongresi, 18 - 20 Nisan 2019, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Over kanserli kadınlarda kas kuvveti, fonksiyonel egzersiz kapasitesi, fonksiyonel mobilite arasındaki ilişki: pilot çalışma

KARADİBAK D., KIZILIRMAK A. S., ÖZSOY İ., GÜÇ Z. G., YAVUZŞEN T., ÖZTOP İ.

7. Ulusal Fizyoterapi ve Rehabilitasyon kongresi, 18 - 20 Nisan 2019, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Over Kanserli Hastalarda Fonksiyonel Egzersiz Kapasitesi ve Fiziksel Aktivite Düzeyi Arasındaki İlişki Pilot Çalışma

KIZILIRMAK A. S., KARADİBAK D., ÖZSOY İ., Güç Z. G., YAVUZŞEN T., ÖZTOP İ.

Ulusal Kanser Kongresi, Türkiye, 17 - 21 Nisan 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

8. KANSER KAŞEKSİ TANISI ALAN HASTALARDAEGZERSİZ KAPASİTESİ, AKTİVİTE DÜZEYİ, KAVRAMAKUVVETİ, SOLUNUM KAS KUVVETİ VE PERİFERİK KASKUVVETİ ARASINDAKİ İLİŞKİNİN İNCELENMESİ

polat k., KARADİBAK D., YAVUZŞEN T., Güç Z. G., ÖZTOP İ.

23. Ulusal kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.289-290, (Özet Bildiri) Sürdürülebilir Kalkınma

9. OVER KANSERLİ HASTALARDA FONKSİYONELEGZERSİZ KAPASİTESİ VE FİZİKSEL AKTİVİTE DÜZEYİARASINDAKİ İLİŞKİSİ: PİLOT ÇALIŞMA

Kızılırmak A. S., KARADİBAK D., ÖZSOY İ., Sevgen Güç Z., YAVUZŞEN T., ÖZTOP İ.

23. Ulusal kanser kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.194-195, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Kemoterapi Tedavisi Alan Akciğer Kanserli Hastalarda Semptom Kümelerinin Belirlenmesi

UĞUR Ö., MERT H., KARADAĞ E., Soydaner Karakuş H., YAVUZŞEN T., ÖZTOP İ., et al.

1. INTERNATIONAL INTERNALMEDICINE NURSINGCONGRESS, 25 - 27 Kasım 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

11. Tıbbi Onkoloji Polikliniğine Başvuran Yeni tanılı kanser Hastalarının Hastalıkalrı Hakkındaki Bilgi ve Farkındalık Düzeyi

ÖN S., Güç Z. G., ELLİDOKUZ H., YAVUZŞEN T., ÖZTOP İ.

Uluslararası Katılımlı 1. Palyatif Bakım Sempozyumu, Türkiye, 28 - 29 Eylül 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

12. Sağ kolon kanserlerinde laparoskopik ve açık cerrahi sonuçlarının karşılaştırılması

YILMAZ İ., BİŞGİN T., ÜNAL M., AĞALAR C., EGELİ T., ÜNLÜ Ş. M., et al.

21. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 11 - 15 Nisan 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Kolorektal karsinom karaciğer metastazlarında iki yönlüdeğerlendirme: Tümör ve parankime ait özelliklerinprognoza etkisi

AYSAL AĞALAR A., AĞALAR C., EGELİ T., ÖZBİLGİN M., ÜNEK T., SOMALI I., et al.

13. Türk Hepatopankreatobilier Cerrahi Kongresi, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

14. The association of clinicopathological features of colorectal cancers with RAS/RAF/MAPK pathway

Baskın Y., Akbarpour M., Çalıbaşı G., Uysal T., Oflazoğlu U., Öztop İ., et al.

4th International Medical Congress, Baku, Azerbaycan, 2 - 03 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

15. KOLOREKTAL KARSİNOM KARACİĞER METASTAZLARINDA İKİ YÖNLÜ DEĞERLENDİRME TÜMÖR VE PARANKİME AİT ÖZELLİKLERİN PROGNOZA ETKİSİ

AYSAL AĞALAR A., AĞALAR C., EGELİ T., ÖZBİLGİN M., ÜNEK T., SOMALI I., et al.

13. TÜRK HEPATOPANKREATOBİLİER CERRAHİ KONGRESİ, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)